Molecular quality control products for use in inherited disease testing, infectious disease detection, and pharmacogenetics.
Âé¶¹Ô´´ Analysis and Insights: Global Molecular Quality Controls Âé¶¹Ô´´
The global Molecular Quality Controls market is projected to grow from US$ 185.6 million in 2024 to US$ 289.6 million by 2030, at a Compound Annual Growth Rate (CAGR) of 7.7% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Molecular Quality Controls market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Molecular Quality Controls, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Molecular Quality Controls, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Molecular Quality Controls revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Molecular Quality Controls market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Molecular Quality Controls revenue, projected growth trends, production technology, application and end-user industry.
Âé¶¹Ô´´ Segmentation
By Company
SeraCare Life Sciences
ZeptoMetrix Corporation
Bio-Rad Laboratories
Microbiologics Inc
Thermo Fisher Scientific
Maine Molecular Quality Controls
Abbott Laboratories
Roche Diagnostics
Quidel Corporation
Qnostics
Segment by Type
Independent
Instrument Specific
Segment by Application
IVD Manufacturers
Research Institute
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Molecular Quality Controls in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Molecular Quality Controls companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Molecular Quality Controls revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Âé¶¹Ô´´ Analysis by Type
1.2.1 Global Molecular Quality Controls Âé¶¹Ô´´ Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Independent
1.2.3 Instrument Specific
1.3 Âé¶¹Ô´´ by Application
1.3.1 Global Molecular Quality Controls Âé¶¹Ô´´ Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 IVD Manufacturers
1.3.3 Research Institute
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Molecular Quality Controls Âé¶¹Ô´´ Perspective (2019-2030)
2.2 Global Molecular Quality Controls Growth Trends by Region
2.2.1 Molecular Quality Controls Âé¶¹Ô´´ Size by Region: 2019 VS 2023 VS 2030
2.2.2 Molecular Quality Controls Historic Âé¶¹Ô´´ Size by Region (2019-2024)
2.2.3 Molecular Quality Controls Forecasted Âé¶¹Ô´´ Size by Region (2025-2030)
2.3 Molecular Quality Controls Âé¶¹Ô´´ Dynamics
2.3.1 Molecular Quality Controls Industry Trends
2.3.2 Molecular Quality Controls Âé¶¹Ô´´ Drivers
2.3.3 Molecular Quality Controls Âé¶¹Ô´´ Challenges
2.3.4 Molecular Quality Controls Âé¶¹Ô´´ Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Molecular Quality Controls by Players
3.1.1 Global Molecular Quality Controls Revenue by Players (2019-2024)
3.1.2 Global Molecular Quality Controls Revenue Âé¶¹Ô´´ Share by Players (2019-2024)
3.2 Global Molecular Quality Controls Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Molecular Quality Controls, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Molecular Quality Controls Âé¶¹Ô´´ Concentration Ratio
3.4.1 Global Molecular Quality Controls Âé¶¹Ô´´ Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Quality Controls Revenue in 2023
3.5 Global Key Players of Molecular Quality Controls Head office and Area Served
3.6 Global Key Players of Molecular Quality Controls, Product and Application
3.7 Global Key Players of Molecular Quality Controls, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Quality Controls Breakdown Data by Type
4.1 Global Molecular Quality Controls Historic Âé¶¹Ô´´ Size by Type (2019-2024)
4.2 Global Molecular Quality Controls Forecasted Âé¶¹Ô´´ Size by Type (2025-2030)
5 Molecular Quality Controls Breakdown Data by Application
5.1 Global Molecular Quality Controls Historic Âé¶¹Ô´´ Size by Application (2019-2024)
5.2 Global Molecular Quality Controls Forecasted Âé¶¹Ô´´ Size by Application (2025-2030)
6 North America
6.1 North America Molecular Quality Controls Âé¶¹Ô´´ Size (2019-2030)
6.2 North America Molecular Quality Controls Âé¶¹Ô´´ Size by Type
6.2.1 North America Molecular Quality Controls Âé¶¹Ô´´ Size by Type (2019-2024)
6.2.2 North America Molecular Quality Controls Âé¶¹Ô´´ Size by Type (2025-2030)
6.2.3 North America Molecular Quality Controls Âé¶¹Ô´´ Share by Type (2019-2030)
6.3 North America Molecular Quality Controls Âé¶¹Ô´´ Size by Application
6.3.1 North America Molecular Quality Controls Âé¶¹Ô´´ Size by Application (2019-2024)
6.3.2 North America Molecular Quality Controls Âé¶¹Ô´´ Size by Application (2025-2030)
6.3.3 North America Molecular Quality Controls Âé¶¹Ô´´ Share by Application (2019-2030)
6.4 North America Molecular Quality Controls Âé¶¹Ô´´ Size by Country
6.4.1 North America Molecular Quality Controls Âé¶¹Ô´´ Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Molecular Quality Controls Âé¶¹Ô´´ Size by Country (2019-2024)
6.4.3 North America Molecular Quality Controls Âé¶¹Ô´´ Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Molecular Quality Controls Âé¶¹Ô´´ Size (2019-2030)
7.2 Europe Molecular Quality Controls Âé¶¹Ô´´ Size by Type
7.2.1 Europe Molecular Quality Controls Âé¶¹Ô´´ Size by Type (2019-2024)
7.2.2 Europe Molecular Quality Controls Âé¶¹Ô´´ Size by Type (2025-2030)
7.2.3 Europe Molecular Quality Controls Âé¶¹Ô´´ Share by Type (2019-2030)
7.3 Europe Molecular Quality Controls Âé¶¹Ô´´ Size by Application
7.3.1 Europe Molecular Quality Controls Âé¶¹Ô´´ Size by Application (2019-2024)
7.3.2 Europe Molecular Quality Controls Âé¶¹Ô´´ Size by Application (2025-2030)
7.3.3 Europe Molecular Quality Controls Âé¶¹Ô´´ Share by Application (2019-2030)
7.4 Europe Molecular Quality Controls Âé¶¹Ô´´ Size by Country
7.4.1 Europe Molecular Quality Controls Âé¶¹Ô´´ Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Molecular Quality Controls Âé¶¹Ô´´ Size by Country (2019-2024)
7.4.3 Europe Molecular Quality Controls Âé¶¹Ô´´ Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Molecular Quality Controls Âé¶¹Ô´´ Size (2019-2030)
8.2 China Molecular Quality Controls Âé¶¹Ô´´ Size by Type
8.2.1 China Molecular Quality Controls Âé¶¹Ô´´ Size by Type (2019-2024)
8.2.2 China Molecular Quality Controls Âé¶¹Ô´´ Size by Type (2025-2030)
8.2.3 China Molecular Quality Controls Âé¶¹Ô´´ Share by Type (2019-2030)
8.3 China Molecular Quality Controls Âé¶¹Ô´´ Size by Application
8.3.1 China Molecular Quality Controls Âé¶¹Ô´´ Size by Application (2019-2024)
8.3.2 China Molecular Quality Controls Âé¶¹Ô´´ Size by Application (2025-2030)
8.3.3 China Molecular Quality Controls Âé¶¹Ô´´ Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Molecular Quality Controls Âé¶¹Ô´´ Size (2019-2030)
9.2 Asia Molecular Quality Controls Âé¶¹Ô´´ Size by Type
9.2.1 Asia Molecular Quality Controls Âé¶¹Ô´´ Size by Type (2019-2024)
9.2.2 Asia Molecular Quality Controls Âé¶¹Ô´´ Size by Type (2025-2030)
9.2.3 Asia Molecular Quality Controls Âé¶¹Ô´´ Share by Type (2019-2030)
9.3 Asia Molecular Quality Controls Âé¶¹Ô´´ Size by Application
9.3.1 Asia Molecular Quality Controls Âé¶¹Ô´´ Size by Application (2019-2024)
9.3.2 Asia Molecular Quality Controls Âé¶¹Ô´´ Size by Application (2025-2030)
9.3.3 Asia Molecular Quality Controls Âé¶¹Ô´´ Share by Application (2019-2030)
9.4 Asia Molecular Quality Controls Âé¶¹Ô´´ Size by Region
9.4.1 Asia Molecular Quality Controls Âé¶¹Ô´´ Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Molecular Quality Controls Âé¶¹Ô´´ Size by Region (2019-2024)
9.4.3 Asia Molecular Quality Controls Âé¶¹Ô´´ Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Molecular Quality Controls Âé¶¹Ô´´ Size (2019-2030)
10.2 Middle East, Africa, and Latin America Molecular Quality Controls Âé¶¹Ô´´ Size by Type
10.2.1 Middle East, Africa, and Latin America Molecular Quality Controls Âé¶¹Ô´´ Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Molecular Quality Controls Âé¶¹Ô´´ Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Molecular Quality Controls Âé¶¹Ô´´ Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Molecular Quality Controls Âé¶¹Ô´´ Size by Application
10.3.1 Middle East, Africa, and Latin America Molecular Quality Controls Âé¶¹Ô´´ Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Molecular Quality Controls Âé¶¹Ô´´ Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Molecular Quality Controls Âé¶¹Ô´´ Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Molecular Quality Controls Âé¶¹Ô´´ Size by Country
10.4.1 Middle East, Africa, and Latin America Molecular Quality Controls Âé¶¹Ô´´ Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Molecular Quality Controls Âé¶¹Ô´´ Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Molecular Quality Controls Âé¶¹Ô´´ Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 SeraCare Life Sciences
11.1.1 SeraCare Life Sciences Company Details
11.1.2 SeraCare Life Sciences Business Overview
11.1.3 SeraCare Life Sciences Molecular Quality Controls Introduction
11.1.4 SeraCare Life Sciences Revenue in Molecular Quality Controls Business (2019-2024)
11.1.5 SeraCare Life Sciences Recent Developments
11.2 ZeptoMetrix Corporation
11.2.1 ZeptoMetrix Corporation Company Details
11.2.2 ZeptoMetrix Corporation Business Overview
11.2.3 ZeptoMetrix Corporation Molecular Quality Controls Introduction
11.2.4 ZeptoMetrix Corporation Revenue in Molecular Quality Controls Business (2019-2024)
11.2.5 ZeptoMetrix Corporation Recent Developments
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Details
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Molecular Quality Controls Introduction
11.3.4 Bio-Rad Laboratories Revenue in Molecular Quality Controls Business (2019-2024)
11.3.5 Bio-Rad Laboratories Recent Developments
11.4 Microbiologics Inc
11.4.1 Microbiologics Inc Company Details
11.4.2 Microbiologics Inc Business Overview
11.4.3 Microbiologics Inc Molecular Quality Controls Introduction
11.4.4 Microbiologics Inc Revenue in Molecular Quality Controls Business (2019-2024)
11.4.5 Microbiologics Inc Recent Developments
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Details
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Molecular Quality Controls Introduction
11.5.4 Thermo Fisher Scientific Revenue in Molecular Quality Controls Business (2019-2024)
11.5.5 Thermo Fisher Scientific Recent Developments
11.6 Maine Molecular Quality Controls
11.6.1 Maine Molecular Quality Controls Company Details
11.6.2 Maine Molecular Quality Controls Business Overview
11.6.3 Maine Molecular Quality Controls Molecular Quality Controls Introduction
11.6.4 Maine Molecular Quality Controls Revenue in Molecular Quality Controls Business (2019-2024)
11.6.5 Maine Molecular Quality Controls Recent Developments
11.7 Abbott Laboratories
11.7.1 Abbott Laboratories Company Details
11.7.2 Abbott Laboratories Business Overview
11.7.3 Abbott Laboratories Molecular Quality Controls Introduction
11.7.4 Abbott Laboratories Revenue in Molecular Quality Controls Business (2019-2024)
11.7.5 Abbott Laboratories Recent Developments
11.8 Roche Diagnostics
11.8.1 Roche Diagnostics Company Details
11.8.2 Roche Diagnostics Business Overview
11.8.3 Roche Diagnostics Molecular Quality Controls Introduction
11.8.4 Roche Diagnostics Revenue in Molecular Quality Controls Business (2019-2024)
11.8.5 Roche Diagnostics Recent Developments
11.9 Quidel Corporation
11.9.1 Quidel Corporation Company Details
11.9.2 Quidel Corporation Business Overview
11.9.3 Quidel Corporation Molecular Quality Controls Introduction
11.9.4 Quidel Corporation Revenue in Molecular Quality Controls Business (2019-2024)
11.9.5 Quidel Corporation Recent Developments
11.10 Qnostics
11.10.1 Qnostics Company Details
11.10.2 Qnostics Business Overview
11.10.3 Qnostics Molecular Quality Controls Introduction
11.10.4 Qnostics Revenue in Molecular Quality Controls Business (2019-2024)
11.10.5 Qnostics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
SeraCare Life Sciences
ZeptoMetrix Corporation
Bio-Rad Laboratories
Microbiologics Inc
Thermo Fisher Scientific
Maine Molecular Quality Controls
Abbott Laboratories
Roche Diagnostics
Quidel Corporation
Qnostics
Ìý
Ìý
*If Applicable.